Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 38, 2020 - Issue 2
Journal homepage
233
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Vorinostat, a possible alternative to metronidazole for the treatment of amebiasis caused by Entamoeba histolytica

S. MontañoLaboratorio de Bioinformática, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa (FCQB-UAS), Blvd. de las Américas y Josefa Ortiz de Domínguez s/n. Ciudad Universitaria, Culiacán Sinaloa, México; View further author information
,
L. A. Constantino-JonapaCentro de Investigación y de Estudios Avanzados del IPN (CINVESTAV -IPN), Mexico City, México; View further author information
,
Y. Sixto-LópezLaboratorio de Modelado Molecular, Bioinformática y Diseño de Fármacos, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, CDMX, México; View further author information
,
V. I. Hernández-RamírezCentro de Investigación y de Estudios Avanzados del IPN (CINVESTAV -IPN), Mexico City, México; ORCID Iconhttp://orcid.org/0000-0001-5469-3170View further author information
ORCID Icon,
A. Hernández-CeruelosÁrea Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N Carretera Pachuca-Actopan, San Agustín Tlaxiaca, Hidalgo, MéxicoView further author information
,
L. C. Romero-QuezadaÁrea Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N Carretera Pachuca-Actopan, San Agustín Tlaxiaca, Hidalgo, MéxicoView further author information
,
J. C. Ruvalcaba-LedezmaÁrea Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N Carretera Pachuca-Actopan, San Agustín Tlaxiaca, Hidalgo, MéxicoView further author information
,
P. Talamás-RohanaCentro de Investigación y de Estudios Avanzados del IPN (CINVESTAV -IPN), Mexico City, México; ORCID Iconhttp://orcid.org/0000-0002-5085-814XView further author information
ORCID Icon &
L. López-ContrerasÁrea Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Circuito Ex Hacienda La Concepción S/N Carretera Pachuca-Actopan, San Agustín Tlaxiaca, Hidalgo, MéxicoCorrespondence[email protected]
View further author information
 show all
Pages 597-603 | Received 05 Oct 2018, Accepted 31 Jan 2019, Published online: 26 Apr 2019

References

  • Azam, A., & Agarwal, S. M. (2007). Targeting amoebiasis: Status and developments. Current Bioactive Compounds, 3(1), 1–10. doi:10.2174/157340707780809590
  • Batcho, P. F., Case, D. A., & Schlick, T. (2001). Optimized particle-mesh Ewald/multiple-time step integration for molecular dynamics simulations. Journal of Chemical Physics, 115(9), 4003–4018. doi:10.1063/1.1389854
  • Bubna, A. K. (2015). Vorinistat – An overview. Indian Journal of Dermatology, 60(4), 419. doi:10.4103/0019-5154.160511
  • Chua, M. J., Arnold, M. S. J., Xu, W., Lancelot, J., Lamotte, S., Späth, F. F., … Andrews, K. T. (2017). Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth. International Journal for Parasitology: Drugs and Drug Resistance, 7(1), 42–50. doi:10.1016/j.ijpddr.2016.12.005
  • Elbadawi, M. A. A., Awadalla, M. K. A., Hamid, M. M. A., Mohamed, M. A., & Awad, T. A. (2015). Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): An in silico approach. International Journal of Molecular Sciences, 16(2), 3915–3931. doi:10.3390/ijms16023915
  • Guo, F., Zhang, H., Mcnair, N. N., Mead, J. R., & Zhu, G. (2018). The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases. The Journal of Infectious Diseases, 217(7), 1110–1117. doi:10.1093/infdis/jix689
  • Loftus, B., Anderson, I., Davies, R., Alsmark, U. C. M., Samuelson, J., Amedeo, P., … Hall, N. (2005). The genome of the protist parasite Entamoeba histolytica. Nature, 433(7028), 865–868. doi:10.1038/nature03291
  • Montaño, S., Orozco, E., Correa-Basurto, J., Bello, M., Chávez-Munguía, B., & Betanzos, A. (2016). Heterodimerization of the Entamoeba histolytica EhCPADH virulence complex through molecular dynamics and protein–protein docking. Journal of Biomolecular Structure Dynamics, 35(3), 486–503. doi:10.1080/07391102.2016.1151831
  • Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
  • Ramakrishnan, G., Gilchrist, C. A., Musa, H., Torok, M. S., Grant, P. A., Mann, B. J., & Petri, W. A. Jr. (2004). Histone acetyltransferases and deacetylase in Entamoeba histolytica. Molecular and Biochemical Parasitology, 138(2), 205–216. doi:10.1016/j.molbiopara.2004.09.002
  • Roy, A., Kucukural, A., & Zhang, Y. (2010). I-TASSER: A unified platform for automated protein structure and function prediction. Nature Protocols, 5(4), 725–738. doi:10.1038/nprot.2010.5
  • Sixto-López, Y., Bello, M., & Correa-Basurto, J. (2018). Insights into structural features of HDAC1 and its selectivity inhibition elucidated by molecular dynamic simulation and Molecular Docking. Journal of Biomolecular Structure and Dynamics. 6, 1–27. doi:10.1080/07391102.2018.1441072
  • Tang, J., Yan, H., & Zhuang, S. (2013). Histone deacetylase as target for treatment of multiple disease. Clinical Science, 124(11), 651–662. doi:10.1042/CS20120504
  • Uba, A. I., & Yelekci, K. (2018). Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: A combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. Journal of Biomolecular Structure and Dynamics, 36(12), 3231–3245. doi:10.1080/07391102.2017.1384402
  • Wang, D. (2009). Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors. Current Topics in Medicinal Chemistry, 9(3), 241–256. doi:10.2174/156802609788085287

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.